Benzinga | Nov 10, 2021 06:07PM EST

Cidara Therapeutics Q3 EPS $(0.37) Up From $(0.41) YoY, Sales $7.08M Up From $2.42M YoY

Cidara Therapeutics (NASDAQ:CDTX) reported quarterly losses of $(0.37) per share. This is a 9.76 percent increase over losses of $(0.41) per share from the same period last year. The company reported $7.08 million in sales this quarter. This is a 192.88 percent increase over sales of $2.42 million the same period last year.